Conor Stewart
Research expert covering health & pharmaceuticals in the UK & Europe
Get in touch with us now| Characteristic | 25-49 | 50-64 |
|---|---|---|
| 2024 | 67.5% | 74.9% |
| 2023 | 67% | 74.9% |
| 2022 | 68.6% | 75% |
| 2021 | 68.9% | 76.4% |
| 2020 | 70.9% | 76.4% |
| 2019 | 70.2% | 76.3% |
| 2018 | 69.4% | 77.3% |
| 2017 | 69.7% | 77.2% |
| 2016 | 70.2% | 78% |
| 2015 | 71.2% | 78.4% |
| 2014 | 71.8% | 70.4% |
| 2013 | 71.5% | 79.5% |
| 2012 | 73.4% | 79.9% |
| 2011 | 73.7% | 80.1% |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Loading statistic...
Download
Source
Source
Release date
May 2025
More information
Region
United Kingdom (England)
Survey time period
2011 to 2024
Age group
25-64 years
Supplementary notes
The source provides the following information: " Coverage is defined as the percentage of eligible women who were screened adequately within the previous 3.5 years or 5.5 years, according to age (3.5 years for women aged 25-49 and 5.5 years for women aged 50-64) on 31 March"
Data is not available prior to 2011.
Citation formats
